Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$96.77
-0.16-0.17%
Last update: Dec 15, 3:13 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Merus (MRUS) stock?
You can purchase shares of Merus (NASDAQ:MRUS) through any online brokerage.
Who are Merus (MRUS) competitors?
Other companies in Merus’s space includes: Immunovant Inc (NASDAQ:IMVT), Avidity Biosciences Inc (NASDAQ:RNA), Cogent Biosciences Inc (NASDAQ:COGT), PTC Therapeutics Inc (NASDAQ:PTCT) and Protagonist Therapeutics Inc (NASDAQ:PTGX).
What is the forecast, or price target, for Merus (MRUS) stock?
Merus has a consensus price target of $85.75.
What is the current price for Merus (MRUS)?
The stock price for Merus (NASDAQ: MRUS) is $96.77 last updated December 15, 2025 at 3:13 PM EST.
Does Merus (MRUS) pay a dividend?
There are no upcoming dividends for Merus.
When is Merus (NASDAQ:MRUS) reporting earnings?
Merus does not have any upcoming earnings scheduled.
Is Merus (MRUS) going to split?
There is no upcoming split for Merus.
What sector and industry does Merus (MRUS) operate in?
Merus is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
